Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Sergio Gloger's publication output changed over time?
ScholarIQpublication output · 1981–2021
Output declined50% over the shown period — from 2 works in 1981 to 1 in 2021.
2
1
1
2
2
1
1
1981198419892013201620172021
What are the most-cited papers on Sergio Gloger?
ScholarIQmost cited works
The Safety, Tolerability, and Efficacy of Once-Daily Memantine (28 mg): A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients with Moderate-to-Severe Alzheimer’s Disease Taking Cholinesterase Inhibitors
George T. Grossberg, Facundo Manes, Ricardo Allegri, Luis Miguel Gutiérrez‐Robledo, Sergio Gloger, Lei Xie, Xiaohu Jia, Vojislav Pejović, M. L. Miller, James L. Perhach, Stephen M. Graham
CNS Drugs. 2013158 CitationsOPEN ACCESS
Long-term safety and efficacy of teriflunomide
Paul O’Connor, Giancarlo Comi, Mark S. Freedman, Aaron Miller, Ludwig Kappos, Jean‐Pierre Bouchard, Christine Lebrun‐Frénay, Jan Mareš, Myriam Bénamor, Karthinathan Thangavelu, Jinjun Liang, Philippe Truffinet, Victoria Lawson, Jerry S. Wolinsky, For the Teriflunomide Multiple Sclerosis Oral (TEMSO) Trial Group and the MRI-AC in Houston, Texas, Teriflunomide Multiple Sclerosis Oral (TEMSO) Trial Group and the MRI-AC in Houston, Texas, E. Maida, Eduard Auff, Franz Fazekas, Thomas Berger, Virender Bhan, J-P Bouchard, Pierre Duquette, Mark S. Freedman, François Grand’Maison, M. Kremenchutzky, Caitlin Bourque, Ruth Ann Marrie, Maria Melanson, D. Patry, Paul O’Connor, Joël Oger, Mark Stefanelli, François Jacques, Pablo Venegas, Manoel Miranda, Nancy Beatriz Sánchez Barrientos, E Tenhamm, Sergio Gloger, Gernot Rohde, Jan Mareš, Jette Lautrup Frederiksen, Egon Stenager, Sulev Haldre, Katrin Gross‐Paju, Irina Elovaara, M-L Sumelahti, J-P Erälinna, J-P Erälinna, Martti Färkkilâ, Hanna Harno, Mauri Reunanen, T. Jolma, Cyrille B. Confavreux, William Camu, Pierre Clavelou, Laurent Magy, Marc Debouverie, Gilles Edan, Christine Lebrun‐Frénay, T. Moreau, Jean Pelletier, E Roullet, Sonia Alamowitch, M. Clanet, P. Hautecoeur, Philippe Damier, L. Rumbach, Andrew Chan, Sebastian Schimrigk, J. Haas, Eckart Lensch, Hans‐Christoph Diener, Volker Limmroth, D. Anders, M. Berghoff, Patrick Oschmann, Martin Stangel, M. Berghoff, Achim Frese, Reinhard Kiefer, Martin Marziniak, Uwe K. Zettl, E. Stark, K. Jendroska, Gerd Reifschneider, Massimo Amato, Giacomo P. Comi, V. Cosi, Pamela Gallo, Claudio Gasperini, Angelo Ghezzi, María Trojano, Carlo Pozzilli, E. Montanari, Cees Zwanikken, P.J.H. Jongen, E.Th.L. van Munster, Raymond Hupperts, Bert Anten
Neurology. 2016126 CitationsOPEN ACCESS
Treatment of spontaneous panic attacks with chlomipramine
Sergio Gloger, Leon Grunhaus, B Birmacher, T Troudart
S116025658. 1981115 Citations
The CUIDEME Study: Determinants of Burden in Chilean Primary Caregivers of Patients with Dementia
Andrea Slachevsky, Marilú Budinich, Claudia Miranda‐Castillo, Javier Núñez-Huasaf, Jaime R. Silva, Carlos Muñoz‐Neira, Sergio Gloger, Oscar Jiménez, Bernardo Martorell, Carolina Delgado
Journal of Alzheimer s Disease. 201358 CitationsOPEN ACCESS
Population-attributable risk of adverse childhood experiences for high suicide risk, psychiatric admissions, and recurrent depression, in depressed outpatients
Sergio Gloger, Pablo Martínez, Alex Behn, M. Victoria Chacón, Marianne Cottin, Dante Diez de Medina, Paul A. Vöhringer
S2737785665. 202158 CitationsOPEN ACCESS
Related on ScholarIQ
Instituto de Salud Pública de Chile
Institution
The Safety, Tolerability, and Efficacy of Once-Daily Memantine (28 mg): A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients with Moderate-to-Severe Alzheimer’s Disease Taking Cholinesterase Inhibitors
Paper
Long-term safety and efficacy of teriflunomide
Paper
Treatment of spontaneous panic attacks with chlomipramine
Paper
The CUIDEME Study: Determinants of Burden in Chilean Primary Caregivers of Patients with Dementia
Paper
Population-attributable risk of adverse childhood experiences for high suicide risk, psychiatric admissions, and recurrent depression, in depressed outpatients
Paper